What is LOPJLB’s current signal on RTSN?

LOPJLB’s latest quantitative signal on Retension Pharmaceuticals Inc. (RTSN) is FLAT. Signals are updated daily.

What market regime is RTSN in?

LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.

What does Retension Pharmaceuticals Inc. (RTSN) do?

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the develo…

Retension Pharmaceuticals Inc. (RTSN)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$11.32+7.50%Close

FLAT

Company news

globenewswire.com · 5d ago

Retension Pharmaceuticals Announces Pricing of Initial Public Offering

Market news & ticker search · RSS for RTSN

FAQ

What is LOPJLB’s current signal on RTSN?: LOPJLB’s latest quantitative signal on Retension Pharmaceuticals Inc. (RTSN) is FLAT. Signals are updated daily.
What market regime is RTSN in?: LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
What does Retension Pharmaceuticals Inc. (RTSN) do?: Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the develo…

Retension Pharmaceuticals Inc. (RTSN)

Key stats

Prediction markets

Company news

FAQ